Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).
Ann Oncol. 2011 May;22(5):1054-1061. doi: 10.1093/annonc/mdq575. Epub 2010 Nov 8.
Ann Oncol. 2011.
PMID: 21059637
Free PMC article.
Clinical Trial.
Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy.
Narváez J, Juarez-López P, LLuch J, Narváez JA, Palmero R, García Del Muro X, Nolla JM, Domingo-Domenech E.
Narváez J, et al.
Autoimmun Rev. 2018 Oct;17(10):1040-1045. doi: 10.1016/j.autrev.2018.05.002. Epub 2018 Aug 10.
Autoimmun Rev. 2018.
PMID: 30103042
Review.
Item in Clipboard
Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature.
Narváez J, Pirola JP, LLuch J, Juarez P, Nolla JM, Valenzuela A.
Narváez J, et al.
Autoimmun Rev. 2019 Mar;18(3):262-269. doi: 10.1016/j.autrev.2018.10.006. Epub 2019 Jan 11.
Autoimmun Rev. 2019.
PMID: 30639647
Item in Clipboard
Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V; ESMO Guidelines Working Group.
Schmoll HJ, et al.
Ann Oncol. 2010 May;21 Suppl 5:v147-54. doi: 10.1093/annonc/mdq177.
Ann Oncol. 2010.
PMID: 20555066
Free article.
No abstract available.
Item in Clipboard
Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V; ESMO Guidelines Working Group.
Schmoll HJ, et al.
Ann Oncol. 2010 May;21 Suppl 5:v140-6. doi: 10.1093/annonc/mdq176.
Ann Oncol. 2010.
PMID: 20555065
Free article.
No abstract available.
Item in Clipboard
[Evaluation of clinical research studies in a comprehensive cancer center].
García M, Lluch JR, Serra C, Pérez X, Berenguer G, Borràs JM.
García M, et al.
Med Clin (Barc). 2004 Feb 21;122(6):212-5. doi: 10.1016/s0025-7753(04)74199-8.
Med Clin (Barc). 2004.
PMID: 15012888
Spanish.
Item in Clipboard
Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain.
Llort G, Muñoz CY, Tuser MP, Guillermo IB, Lluch JR, Bale AE, Franco MA.
Llort G, et al.
Hum Mutat. 2002 Mar;19(3):307. doi: 10.1002/humu.9014.
Hum Mutat. 2002.
PMID: 11857748
Item in Clipboard
Cite
Cite